Investment
Features
FeesSafety
Academy
More
Pluang+

Compare HF Sinclair Corporation Common Stock (DINO) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance

HF Sinclair Corporation Common StockTrade
Ginkgo Bioworks Holdings IncTrade

Price performance (Past 24H)

Key statistics

HF Sinclair Corporation Common Stock vs Ginkgo Bioworks Holdings Inc — how do they compare? HF Sinclair Corporation Common Stock trades at $120.83 (market cap $21.46B), while Ginkgo Bioworks Holdings Inc trades at $12.95 (market cap $763.64M). The key difference: HF Sinclair Corporation Common Stock is far larger — about 28.1× Ginkgo Bioworks Holdings Inc's market cap, and HF Sinclair Corporation Common Stock pays a 1.74% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold HF Sinclair Corporation Common Stock for 0 Days and Ginkgo Bioworks Holdings Inc for 7 Days on average.

DINODNA
Market Cap
$21.46B$763.64M
Volume
2,430,5803,204,177
Sector
EnergyHealth
52-Week High
$120.72$15.83
52-Week Low
$45.88$5.48
Typical Hold Time
0 Days7 Days
Enterprise Value
$22.44B$865.59M
Dividend Yield
1.74%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

HF Sinclair Corporation Common Stock

No Aura AI signal available yet.

Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks (DNA) trades at $13.04, up 13.69% in the last session, with a bullish technical signal from moving averages. The company maintains strong gross margins at 68.04% but faces significant losses with a -219.6% net income margin. Recent developments include a $17.5M ARPA-H subcontract for RNA medicine manufacturing and partnerships expanding genetic testing distribution.

While technical momentum appears positive, fundamental challenges persist with substantial cash burn and declining revenue projections. Analyst sentiment is divided equally between buy, hold, and sell ratings. Investment opportunity lies in the company's strategic partnerships and government contracts, balanced against ongoing profitability concerns and competitive pressures in biotech.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DINO
100% Buy0% Sell
Avg holding period · 0 Days
DNA
47% Buy53% Sell
Avg holding period · 7 Days

Top news

Latest headlines on both assets

About HF Sinclair Corporation Common Stock

HF Sinclair refines and markets petroleum products, including gasoline, diesel, and jet fuel. It also operates logistics and renewable fuels businesses.

Read more on DINO →

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.

Read more on DNA →